e-Drug3D 1504 |
CABAZITAXEL
|
cas 183133-96-2 |
CLASS ANTINEOPLASTIC |
ROUTE (list) INTRAVENOUS INJECTION |
ATC code |
PK parameters VD 4864 LITER Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET MICROTUBULE |
DrugCentral Tubulin beta UNIPROT P07437 TUBB |
Download SDF file | Benzenepropanoic acid, beta-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (alphaR,betaS)- Formula: Calculated chemical properties: MW 835.92 NB_atoms 60 XLogP 4.57 PSA 165.574 NB_HD 3 NB_HA 15 fsp3 0.58 Lipinski(0=no;1=yes) 0 |
FDA NDA 201023 (pdf not found) INN (CABAZITAXEL) JEVTANA KIT (SANOFI AVENTIS US) APPROVAL= AP YEAR= 2010 NDA 207937 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (FRESENIUS KABI USA) APPROVAL= TA YEAR= 2019 NDA 207949 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 207693 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2022 NDA 207619 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (BRECKENRIDGE) APPROVAL= AP YEAR= 2022 DISCONTINUED NDA 207736 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (APOTEX) APPROVAL= AP YEAR= 2023 DISCONTINUED NDA 208715 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (SANDOZ) APPROVAL= TA YEAR= 2023 NDA 207718 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (DR REDDYS) APPROVAL= AP YEAR= 2023 NDA 207735 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (BPI LABS LLC) APPROVAL= TA YEAR= 2023 NDA 207381 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (MYLAN LABS LTD) APPROVAL= AP YEAR= 2023 DISCONTINUED NDA 207970 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (ACTAVIS) APPROVAL= AP YEAR= 2024 DISCONTINUED |
Other links: |